Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulating agents.

Cecil P Moore1

  • 1Department of Veterinary Medicine and Surgery, A383 Clydesdale Hall, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA. moorec@missouri.edu

The Veterinary Clinics of North America. Small Animal Practice
|April 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bilateral retinoschisis in a dog: A veterinary clinical application for optical coherence tomography.

Veterinary ophthalmology·2018
Same author

Uveal schwannoma in a brown-eyed dog.

Veterinary ophthalmology·2017
Same author

Local photodynamic therapy delays recurrence of equine periocular squamous cell carcinoma compared to cryotherapy.

Veterinary ophthalmology·2014
Same author

Long-term outcome of sudden acquired retinal degeneration syndrome in dogs.

Journal of the American Veterinary Medical Association·2013
Same author

The pharmacologic assessment of a novel lymphocyte function-associated antigen-1 antagonist (SAR 1118) for the treatment of keratoconjunctivitis sicca in dogs.

Investigative ophthalmology & visual science·2011
Same author

In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.

Veterinary ophthalmology·2009
Same journal

Regulation of Artificial Intelligence in Veterinary Medicine.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Practical Steps Toward Antimicrobial Stewardship for the General Practitioner.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Using Evidence-Based Veterinary Medicine and Artificial Intelligence to Support Clinical Decision Making in Veterinary Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Feline Asthma-Update on Diagnosis and Treatment Recommendations.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

Disease Prediction and Precision Veterinary Medicine: Applications, Opportunities, and Limitations of Artificial Intelligence in Small Animal Practice.

The Veterinary clinics of North America. Small animal practice·2026
Same journal

The Moving Target of Companion Animal Infectious Diseases: Emerging Threats and Evolving Solutions.

The Veterinary clinics of North America. Small animal practice·2026
See all related articles

Veterinary ophthalmology increasingly uses immunosuppressive agents for chronic ocular inflammation due to complex immune responses and limitations of traditional therapies. Immunomodulating agents also aid in managing visual system diseases.

Area of Science:

  • Immunology
  • Veterinary Medicine
  • Ophthalmology

Background:

  • Inflammation involves complex molecular cascades orchestrated by immune system biochemicals.
  • Adaptive immunity develops with persistent exposure to immunogenic agents, potentially causing detrimental immune-mediated processes.
  • Conventional anti-inflammatory therapies have limitations in managing chronic ocular inflammation.

Purpose of the Study:

  • To review the role of alternative chemotherapeutic agents in veterinary ophthalmology.
  • To highlight the use of immunosuppressive and immunomodulating agents in ocular disease management.

Main Methods:

  • Literature review of current therapeutic strategies in veterinary ophthalmology.
  • Analysis of the mechanisms and applications of immunosuppressive agents.

Related Experiment Videos

  • Evaluation of immunomodulating agents as adjunctive therapies.

    • Main Results:

    • Chemotherapeutic immunosuppressive agents are increasingly vital for chronic ocular inflammatory diseases.
    • Non-immunosuppressive immunomodulating agents serve as valuable adjunctive therapies.
    • These agents address complexities beyond traditional anti-inflammatory mechanisms.

    Conclusions:

    • Advanced immunosuppressive and immunomodulating therapies are essential in managing complex veterinary ocular inflammatory conditions.
    • These agents offer alternatives and complements to conventional treatments, improving patient outcomes.